Joshua G. Travers
University of Colorado Anschutz Medical Campus
ORCID: 0000-0002-5660-2620Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 11 papers. Top paper: “HDAC Inhibition Reverses Preexisting Diastolic Dysfunction and Blocks Covert Extracellular Matrix Remodeling”.
Sara A. Wennersten, Brisa Peña, Rushita A. Bagchi, Harrison E. Smith, Rachel Hirsch +13 more
Arun Padmanabhan, Tomohiro Nishino, Joshua G. Travers, Lin Ye, Angelo Pelonero +25 more
Dominic C. M. Ng, Jordan Currie, Alexander Black, Boomathi Pandi, Vyshnavi Manda +7 more
Dominic C. M. Ng, Jordan Currie, Alexander Black, Boomathi Pandi, Vyshnavi Manda +7 more
Tianjing Hu, Timothy A. McKinsey, Joshua G. Travers
Jennifer L. Major, Tim Liebner, Zaynab Hourani, Joshua G. Travers, Sara A. Wennersten +14 more
Joshua G. Travers, Elizabeth J. Hardy, Matthew J. Wolf, Timothy A. McKinsey, Jeffrey J. Saucerman +1 more
Roger S. Y. Foo, Chukwuemeka George Anene-Nzelu, Joshua G. Travers, Ronald J. Vagnozzi, Natalie Weber +2 more
Joshua G. Travers, Timothy A. McKinsey, Kathleen C. Woulfe
Faculty Opinions recommendation of GRK5 is a regulator of fibroblast activation and cardiac fibrosis.
Joshua G. Travers, Timothy A. McKinsey
Charles A. Tharp, Marcello Rubino, Timothy A. McKinsey, Joshua G. Travers